AVXL logo

Anavex Life Sciences Corp. (AVXL)

$0.74

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on AVXL

Market cap

$68595663

EPS

-0.15

P/E ratio

--

Price to sales

--

Dividend yield

--

Beta

1.237997

Price on AVXL

Previous close

$0.82

Today's open

$0.83

Day's range

$0.71 - $0.84

52 week range

$0.71 - $5.36

Profile about AVXL

CEO

Terrie Kellmeyer

Employees

34

Headquarters

New York, NY

Exchange

Nasdaq Global Select

Shares outstanding

92696842

Issue type

Common Stock

AVXL industries and sectors

Healthcare

Biotechnology & Life Sciences

News on AVXL

ANAVEX DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important November 30 Deadline in Securities Class Action First Filed by the Firm – AVXL

NEW YORK, Nov. 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the “Class Period”), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

news source

GlobeNewsWire • an hour ago

news preview

Kaplan Fox Advises Investors of Anavex Life Sciences Corp. (AVXL) of an Upcoming Securities Class Action Deadline on November 30, 2026

New York, New York--(Newsfile Corp. - November 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Anavex and have suffered losses, you may CLICK HERE to contact us.

news source

Newsfile Corp • 9 hours ago

news preview

AVXL EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Anavex (AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 18, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

news source

Newsfile Corp • 5 hours ago

news preview

DEADLINE ALERT for Fluence Energy, Inc. (FLNC), Qfin Holdings, Inc. (QFIN), Endava plc (DAVA), and Anavex Life Sciences Corp. (AVXL): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions

Investors in Fluence Energy, Inc., Qfin Holdings, Inc., Endava plc, and Anavex Life Sciences Corp. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions Investors in Fluence Energy, Inc., Qfin Holdings, Inc., Endava plc, and Anavex Life Sciences Corp. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions

news source

GlobeNewsWire • 3 hours ago

news preview

Anavex Life Sciences, Corp. (NASDAQ: AVXL) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Anavex Life Sciences, Corp. Securities Lawsuit - Contact Portnoy Law Firm

LOS ANGELES, Nov. 17, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm notifies investors in Anavex Life Sciences, Corp. (NASDAQ: AVXL) that a securities class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Anavex common stock between November 26, 2025 and August 28, 2026, inclusive (the 'Class Period'). Find out if you qualify to recover your per-share losses by choosing to join the class action and submit your trade details . Investors who suffered financial losses have until November 30, 2026 to seek appointment as lead plaintiff. Shareholders should contact Lesley Portnoy via e-mail (Lesley@portnoylaw.com or call (310) 692-8883) or visit http://portnoylaw.com/anavex-life-sciences-corp to learn more information and discuss their legal rights.

news source

GlobeNewsWire • Nov 17, 2026

news preview

Deadline Alert: Anavex Life Sciences Corp. Investors Have Until November 30, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

Class action covers investors who bought Anavex Life Sciences Corp. securities between November 26, 2025 and August 28, 2026; complaint alleges the company failed to disclose material adverse facts Class action covers investors who bought Anavex Life Sciences Corp. securities between November 26, 2025 and August 28, 2026; complaint alleges the company failed to disclose material adverse facts

news source

GlobeNewsWire • Nov 17, 2026

news preview

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines – AVXL

NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

news source

GlobeNewsWire • 20 hours ago

news preview

Bronstein, Gewirtz & Grossman LLC Urges Anavex Life Sciences Corp. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - November 17, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period").

news source

Newsfile Corp • Nov 17, 2026

news preview

AVXL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 30 Deadline in Securities Class Action First Filed by the Firm - AVXL

New York, New York--(Newsfile Corp. - November 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

news source

Newsfile Corp • Nov 17, 2026

news preview

SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Anavex Life Sciences Corp. (NASDAQ: AVXL) — Investors Who Suffered Losses Are Encouraged to Contact the Firm

Lead Plaintiff Deadline: November 30, 2026. Investors who purchased (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026 may be eligible to recover losses.

news source

GlobeNewsWire • Nov 16, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Anavex Life Sciences Corp.

Open an M1 investment account to buy and sell Anavex Life Sciences Corp. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in AVXL on M1